本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Castle Biosciences, Inc.

18.91
+0.37002.00%
盘后18.910.00000.00%16:04 EDT
成交量:33.55万
成交额:629.48万
市值:5.46亿
市盈率:-102.51
高:19.06
开:18.51
低:17.89
收:18.54
数据加载中...
2020/03/10

员工持股计划

Securities to be offered to employees in employee benefit plans
2020/03/10

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/10

重要事件披露

Current report, items 2.02, 7.01, and 9.01
2020/03/05

重要事件披露

Current report, items 1.01 and 2.04
2020/02/12

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/12

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/11

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/05

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/01/09

重要事件披露

Current report, items 2.02, 7.01, and 9.01
2019/12/19

重要事件披露

Current report, items 1.01, 5.02, and 9.01
2019/11/14

重要事件披露

Current report, items 2.02, 7.01, and 9.01
2019/11/12

重要事件披露

Current report, items 2.02 and 9.01
2019/11/12

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/09/03

重要事件披露

Current report, items 2.02 and 9.01
2019/09/03

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/08/05

超过5%披露

General statement of acquisition of beneficial ownership
2019/07/31

持股变动声明

Statement of changes in beneficial ownership of securities
2019/07/31

持股变动声明

Statement of changes in beneficial ownership of securities
2019/07/31

持股变动声明

Statement of changes in beneficial ownership of securities
2019/07/31

持股变动声明

Statement of changes in beneficial ownership of securities